$12.0644
0.0094[0.08%]
At close: Apr 24
$12.0644
0[0.00%]
PreMarket: 7:30AM EDT
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
Date Announced | ticker | Company Name | Period | Period Year | Min EPS | Max EPS | Estimate | Min Rev | Max Rev | Revenue Estimate | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|
01/08/2024 | NVCR | NovoCure | FY | 2023 | — | — | — | $509.30M | $509.30M | $505.05M | Get Alert |
01/08/2024 | NVCR | NovoCure | Q4 | 2023 | — | — | — | $133.80M | $133.80M | $129.30M | Get Alert |
01/09/2023 | NVCR | NovoCure | FY | 2022 | — | — | — | $537.80M | $537.80M | $538.28M | Get Alert |
01/09/2023 | NVCR | NovoCure | Q4 | 2022 | — | — | — | $128.40M | $128.40M | $129.14M | Get Alert |
01/10/2022 | NVCR | NovoCure | FY | 2021 | — | — | — | $535.00M | $535.00M | $539.23M | Get Alert |
01/10/2022 | NVCR | NovoCure | Q4 | 2021 | — | — | — | $133.20M | $133.20M | $137.36M | Get Alert |
01/11/2021 | NVCR | NovoCure | Q4 | 2020 | — | — | — | $144.00M | $144.00M | $133.26M | Get Alert |
01/11/2021 | NVCR | NovoCure | FY | 2020 | — | — | — | $494.40M | $494.40M | $482.29M | Get Alert |
01/13/2020 | NVCR | NovoCure | Q4 | 2019 | — | — | — | $99.20M | $99.20M | $95.65M | Get Alert |
01/13/2020 | NVCR | NovoCure | FY | 2019 | — | — | — | $351.30M | $351.30M | $347.69M | Get Alert |
There have been no specific sales or earnings guidance reported for NovoCure in recent months.
Browse guidance and forecast on all stocks.